Latest News
FuelCell Energy Rides Bloom Energy's AI Data Center Tailwind
FuelCell Energy stock surged Wednesday as investor enthusiasm for fuel-cell stocks was reignited by Bloom Energy's robust earnings and its Oracle data center contract.
Plug Power Shares Surge on Analyst Upgrade and Sector Rally Ahead of Earnings
Plug Power shares surged 10% on heavy volume after a price target hike and a sector-wide fuel cell rally, ahead of its May 11 earnings report.
Rising Dragon Stock Skyrockets on SPAC Extension Proposal
RDAC shares soared 400% to $21.72 on news of a proposed deadline extension for its HZJL SPAC merger, with a shareholder vote scheduled for May 28.
Upstart Shares Slip on Fortress Loan Deal as Investor Caution Lingers
Upstart shares fell after announcing a $1.25 billion loan purchase deal with Fortress Investment Group. Despite strong 2025 results, investors remain cautious about funding risks.
McDonald's Enters Specialty Drink Wars with New Refresher and Craft Soda Lineup
McDonald's will introduce six specialty drinks, including Refreshers and crafted sodas, on May 6. The move aims to capture afternoon traffic and boost margins.
Gold Slides for Third Day as Fed Policy and Iran Tensions Weigh
Gold dropped for a third day to $4,545.20 as traders weighed Fed rate policy and Iran war fears. Brent crude neared $119, Treasury yields climbed.
Sagtec Global Soars on Record Revenue, But Profit Pressures Loom
Sagtec Global shares jumped 38% on record 2025 revenue of $19.1M, up 49%, driven by services growth. But operating income fell 9% and EPS dropped to $0.09, reflecting expansion costs after its Nasdaq IPO.
Dow Drops for Fifth Straight Session as Oil Surge, Fed Decision Loom
The Dow Jones Industrial Average fell 320 points as traders braced for the Fed's rate decision, big tech earnings, and an oil shock from a potential Iran blockade.
General Dynamics Soars on Strong Submarine, Jet Orders; 2026 Outlook Raised
General Dynamics shares surged 10.9% after Q1 earnings and revenue topped estimates, driven by submarine and Gulfstream jet orders, lifting its 2026 outlook.
Teva Surges 11% as Branded Drugs Drive Q1 Beat, Emalex Deal Adds Tourette Candidate
Teva beat Q1 estimates with adjusted EPS of $0.53 on $3.98B revenue, as branded drug sales surged 41%. Shares rose 11% on the news.